Financing ·
Genmab A/S increased its share capital by 24,592 shares following the exercise of employee warrants
GNMSFGenmab A/S
Genmab A/S increased its share capital by 24,592 shares following the exercise of employee warrants. The company raised approximately DKK 37.9 million in proceeds through cash subscriptions at prices ranging from DKK 1,334.50 to DKK 1,615.00 per share. This transaction represents roughly 0.04% of total share capital and was executed without preemption rights for existing shareholders. Genmab is an international biotechnology company dedicated to developing innovative antibody medicines for cancer and other serious diseases.